Editas Medicine
EDIT
$5.47
Share price
4.99%
Change (1 day)
-34.10%
Change (1 year)
Operating Margin for Editas Medicine (EDIT)
Operating Margin as of May 2024 (TTM): -992.32%
According to Editas Medicine 's latest financial reports and stock price the company's current Operating Margin is -992.32%. At the end of 2021 the company had an Operating Margin of -753.61%.
Operating Margin history for Editas Medicine from 2016 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -753.61% | 489.57% |
| 2020 | -127.82% | -80.38% |
| 2019 | -651.43% | 89.21% |
| 2018 | -344.28% | -60.72% |
| 2017 | -876.49% | -45.41% |
| 2016 | -1,605.53% | -64.12% |
| 2015 | -4,475.14% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -591.52% | -40.39% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -129.00% | -87.00% | 🇬🇧 UK |
 Novavax NVAX | -149.57% | -84.93% | 🇺🇸 USA |
 Novocure
NVCR | -37.52% | -96.22% | Jersey |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.